FDLI's Food and Drug Law Journal Celebrates its 70th Volume with Georgetown University Partnership

WASHINGTON, March 10, 2015 /PRNewswire-USNewswire/ -- The Food and Drug Law Institute (FDLI) is celebrating its esteemed Food and Drug Law Journal's 70th volume in 2015. FDLI is delighted to announce its partnership to co-publish the Food and Drug Law Journal with the Georgetown University Law Center and the O'Neill Institute for National and Global Health Law. The Journal is today's premier source for scholarly articles that examine and discuss the progress of laws and regulations in the fields of food, drugs, biologics, cosmetics, dietary supplements, medical devices, and tobacco products.

"The Food and Drug Law Journal has served as the leading source of scholarly analysis for food and drug law lawyers, regulators, and academics for many years.  The Journal will now be made even stronger with co-publication with the Georgetown University Law Center, one of the best law schools in the country," said Amy Comstock Rick, President and CEO of FDLI. "We look forward to working with law students and Georgetown faculty as the new phase of this excellent publication moves forward." 

With the new partnership, FDLI staff will continue to serve in the role of editor-in-chief. Additionally, FDLI members will comprise the Editorial Advisory Board, providing the same level of rigorous peer review and experience reflected in past Journal issues.  With the addition of expertise housed within the O'Neill Institute and commitment from faculty advisors and other members of the Georgetown Law community, the Journal will now serve an even broader academic and professional community as a place for discourse, analysis, and debate at the highest level. 

"We are delighted to collaborate with the Food and Drug Law Institute on this important publication," said Georgetown Law Dean William M. Treanor. "This partnership will provide an outstanding opportunity for our students who are interested in food and drug law."

To maintain its highly regarded reputation and authority in the field, FDLI places great emphasis on providing information from the perspective of practitioners, scholars, public policy professionals. Qualified professionals are encouraged to submit a manuscript for consideration. For more information please visit the FDLI website or contact [email protected].

FDLI is a 501(3)(c) non-profit organization located in Washington, DC, dedicated to providing an innovative, open, balanced exchange of ideas and viewpoints across the fields of global food and drug law. FDLI's mission is to provide topical and timely education, training, and publications, foster professional relationships and to act as a liaison to inform public policy, law, and regulation. All FDLI members receive free access to the Journal, which is published quarterly. Complimentary Journal subscription is a benefit afforded to many FDLI members. Non-qualifying members or non-members may subscribe online. Please visit FDLI's website to learn more.

Contact: Liz Stevulak
Phone: (202) 222-0892
Email: [email protected]

SOURCE Food and Drug Law Institute

Related Links

http://www.fdli.org